A novel animal model of human breast cancer metastasis to the spine: a pilot study using intracardiac injection and luciferase-expressing cells

Presented at the 2012 Spine Section Meeting 

Restricted access

Object

Metastatic spine disease is prevalent in cancer victims; 10%–30% of the 1.2 million new patients diagnosed with cancer in the US exhibit spinal metastases. Unfortunately, treatments are limited for these patients, as disseminated disease is often refractory to chemotherapy and is difficult to treat with surgical intervention alone. New animal models that accurately recapitulate the human disease process are needed to study the behavior of metastases in real time.

Methods

In this study the authors report on a cell line that reliably generates bony metastases following intracardiac injection and can be tracked in real time using optical bioluminescence imaging. This line, RBC3, was derived from a metastatic breast adenocarcinoma lesion arising in the osseous spine of a rat following intracardiac injection of MDA-231 human breast cancer cells.

Results

Upon culture and reinjection of RBC3, a statistically significantly increased systemic burden of metastatic tumor was noted. The resultant spine lesions were osteolytic, as demonstrated by small animal CT scanning.

Conclusions

This cell line generates spinal metastases that can be tracked in real time and may serve as a useful tool in the study of metastatic disease in the spine.

Abbreviations used in this paper:BLI = bioluminescence imaging; FBS = fetal bovine serum; SARRP = small animal radiation research platform; VB = vertebral body.

Article Information

Address correspondence to: Daniel Sciubba, M.D., 600 North Wolfe Street, Meyer 5-185, Baltimore, Maryland 21287. email: dsciubb1@jhmi.edu.

Please include this information when citing this paper: published online December 21, 2012; DOI: 10.3171/2012.11.SPINE12325.

© AANS, except where prohibited by US copyright law.

Headings

Figures

  • View in gallery

    Bioluminescence of MDA-231 cells following intracardiac injection. Rats are shown on Days 10 (A), 34 (B), and 46 (C) after intracardiac injection of MDA-231 cells. A: Bioluminescence positivity is diffuse on Day 10. B: By Day 34, 3 animals demonstrate focal bioluminescence positivity in the spine. C: The surviving animals are shown on Day 46, with bioluminescence in the forepaw, femur, and hindpaw.

  • View in gallery

    Small animal CT scanning and bioluminescent signal of osteolytic metastasis. A: Bioluminescence signal in lumbar spine of 1 rat following intracardiac injection of MDA-231 cells. The inset highlights full body metastasis. B: Small animal CT scanning confirms osteolysis of the posterior elements of lumbar spine (arrow) with decrease in calcium in the location of bioluminescent signal.

  • View in gallery

    Bioluminescence of MDA-231 cells after intracardiac injection. A: Animals are shown on Day 34 after intracardiac injection. Metastases are evident in the spine in all 3 animals. Additional metastases are noted in the anatomical locations of the scapula, lung, femur, forepaw, tail, hindpaw, and brain. B and C: Cells were recovered from the spinal lesions in Rat 3 (A, right). These cells were luciferase (B) and GFP (C) positive, confirming their source as the MDA-231 cell line.

  • View in gallery

    Bioluminescence of RBC3 cells following intracardiac injection. Rats are shown on Days 11 (A), 34 (B), and 43 (C) after intracardiac injection of RBC3 cells. A: Bioluminescence positivity is diffuse on Day 11. B: By Day 34, 6 animals demonstrate focal bioluminescence positivity in the spine. C: On Day 43, the remaining animals demonstrate marked progression of metastatic disease to bilateral femurs, multiple foci in the lumbar spine, scapula, and fore- and hindpaws. One animal did not demonstrate bioluminescence at any time during the study.

  • View in gallery

    Small animal CT scanning and bioluminescent signal of osteolytic metastasis. A: Bioluminescence signal in lumbar spine of rat following intracardiac injection of RBC3 cells. B: Computed tomography scan confirming osteolysis of the posterior elements of lumbar spine (arrow) in the location of the bioluminescent signal.

  • View in gallery

    Kaplan-Meier survival curve. Survival times to paralysis for MDA-231 and RBC3 intracardiac-injected rats are shown. The difference between the curves was not statistically significant (p = 0.277).

  • View in gallery

    Quantification of the total tumor burden. Tumor burden was measured in radiance on Day 34 for all animals. The average tumor burden is shown. Error bars indicate standard deviation. There was a statistically significant difference in tumor burden between the groups (p = 0.013, Student t-test).

  • View in gallery

    Photomicrographs of metastatic lesions. Metastatic lesions were excised en bloc and stained with H & E for analysis. A–C: Aggressive invasion of metastatic adenocarcinoma into the immature trabecular bone can be seen. D: Complete ablation of the bony trabeculae with invasion of the musculature. Specimens from an L-5 lesion on Day 34 (A), L-1 on Day 43 (B), L-2 on Day 43 (C), and S-1 on Day 53 (D) are shown. All lesions were excised from RBC3 intracardiac-injected animals.

References

1

Abrahm JLBanffy MBHarris MB: Spinal cord compression in patients with advanced metastatic cancer: “all I care about is walking and living my life. JAMA 299:9379462008

2

Bagley CABookland MJPindrik JAOzmen TGokaslan ZLWitham TF: Local delivery of oncogel delays paresis in rat metastatic spinal tumor model. J Neurosurg Spine 7:1941982007

3

Bagley CABookland MJPindrik JAOzmen TGokaslan ZLWolinsky JP: Fractionated, single-port radiotherapy delays paresis in a metastatic spinal tumor model in rats. J Neurosurg Spine 7:3233272007

4

Barron KDHirano AAraki STerry RD: Experiences with metastatic neoplasms involving the spinal cord. Neurology 9:911061959

5

Baschnagel ARusso ABurgan WECarter DBeam KPalmieri D: Vorinostat enhances the radiosensitivity of a breast cancer brain metastatic cell line grown in vitro and as intracranial xenografts. Mol Cancer Ther 8:158915952009

6

Burch SBisland SKBogaards AYee AJWhyne CMFinkelstein JA: Photodynamic therapy for the treatment of vertebral metastases in a rat model of human breast carcinoma. J Orthop Res 23:99510032005

7

Burch SBisland SKWilson BCWhyne CYee AJ: Multimodality imaging for vertebral metastases in a rat osteolytic model. Clin Orthop Relat Res 454:2302362007

8

Coghlin CMurray GI: Current and emerging concepts in tumour metastasis. J Pathol 222:1152010

9

Comsa DCFarrell TJPatterson MS: Bioluminescence imaging of point sources implanted in small animals post mortem: evaluation of a method for estimating source strength and depth. Phys Med Biol 52:541554282007

10

DeRose YSWang GLin YCBernard PSBuys SSEbbert MT: Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes. Nat Med 17:151415202011

11

Eleraky MPapanastassiou IVrionis FD: Management of metastatic spine disease. Curr Opin Support Palliat Care 4:1821882010

12

Fitzgerald DPSubramanian PDeshpande MGraves CGordon IQian Y: Opposing effects of pigment epithelium-derived factor on breast cancer cell versus neuronal survival: implication for brain metastasis and metastasis-induced brain damage. Cancer Res 72:1441532012

13

Gerges NRak JJabado N: New technologies for the detection of circulating tumour cells. Br Med Bull 94:49642010

14

Gok BMcGirt MSciubba DMAyhan SBydon AWitham TF: Surgical resection plus adjuvant radiotherapy is superior to surgery or radiotherapy alone in the prevention of neurological decline in a rat metastatic spinal tumor model. Neurosurgery 63:3463512008

15

Gril BPalmieri DBronder JLHerring JMVega-Valle EFeigenbaum L: Effect of lapatinib on the outgrowth of metastatic breast cancer cells to the brain. J Natl Cancer Inst 100:109211032008

16

Gril BPalmieri DQian YSmart DIleva LLiewehr DJ: Pazopanib reveals a role for tumor cell B-Raf in the prevention of HER2+ breast cancer brain metastasis. Clin Cancer Res 17:1421532011

17

Harlaar NJHesselink JWde Jong JSvan Dam GM: Bioluminescence as gold standard for validation of optical imaging modalities in peritoneal carcinomatosis animal models. Eur Surg Res 45:3083132010

18

Kuperwasser CDessain SBierbaum BEGarnet DSperandio KGauvin GP: A mouse model of human breast cancer metastasis to human bone. Cancer Res 65:613061382005

19

Liang HMa SYMohammad KGuise TABalian GShen FH: The reaction of bone to tumor growth from human breast cancer cells in a rat spine single metastasis model. Spine (Phila Pa 1976) 36:4975042011

20

Lockman PRMittapalli RKTaskar KSRudraraju VGril BBohn KA: Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer. Clin Cancer Res 16:566456782010

21

Mantha ALegnani FGBagley CAGallia GLGaronzik IPradilla G: A novel rat model for the study of intraosseous metastatic spine cancer. J Neurosurg Spine 2:3033072005

22

Papachristou DJBasdra EKPapavassiliou AG: Bone metastases: molecular mechanisms and novel therapeutic interventions. Med Res Rev 32:6116362012

23

Patel JBAppaiah HNBurnett RMBhat-Nakshatri PWang GMehta R: Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22. Oncogene 30:129013012011

24

Qian YHua EBisht KWoditschka SSkordos KWLiewehr DJ: Inhibition of Polo-like kinase 1 prevents the growth of metastatic breast cancer cells in the brain. Clin Exp Metastasis 28:8999082011

25

Rosol TJTannehill-Gregg SHLeRoy BEMandl SContag CH: Animal models of bone metastasis. Cancer 97:3 Suppl7487572003

26

Sciubba DMGokaslan ZL: Diagnosis and management of metastatic spine disease. Surg Oncol 15:1411512006

27

Sciubba DMPetteys RJDekutoski MBFisher CGFehlings MGOndra SL: Diagnosis and management of metastatic spine disease. A review. J Neurosurg Spine 13:941082010

28

Smith HS: Painful osseous metastases. Pain Physician 14:E373E4032011

29

Smorgick YMirovsky YShalmon ELotan RDotan AAnekstein Y: [Diagnosis and treatment of spine metastases.]. Harefuah 146:3583632007. (Hebrew)

30

Song HTJordan EKLewis BKLiu WGanjei JKlaunberg B: Rat model of metastatic breast cancer monitored by MRI at 3 tesla and bioluminescence imaging with histological correlation. J Transl Med 7:882009

31

White APKwon BKLindskog DMFriedlaender GEGrauer JN: Metastatic disease of the spine. J Am Acad Orthop Surg 14:5875982006

32

Won EWise-Milestone LAkens MKBurch SYee AJWilson BC: Beyond bisphosphonates: photodynamic therapy structurally augments metastatically involved vertebrae and destroys tumor tissue. Breast Cancer Res Treat 124:1111192010

33

Wong JArmour EKazanzides PIordachita ITryggestad EDeng H: High-resolution, small animal radiation research platform with x-ray tomographic guidance capabilities. Int J Radiat Oncol Biol Phys 71:159115992008

34

Xia TSWang JYin HDing QZhang YFYang HW: Human tissue-specific microenvironment: an essential requirement for mouse models of breast cancer. Oncol Rep 24:2032112010

TrendMD

Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 43 43 13
Full Text Views 46 46 7
PDF Downloads 78 78 30
EPUB Downloads 0 0 0

PubMed

Google Scholar